JW Pharmaceutical Buys Group's VC Arm Solidus for $22 Million
JW Pharmaceutical has agreed to acquire Solidus, the venture capital arm of its own business group, for $22 million, Dealroom.co reports. The deal folds the group's corporate investment vehicle into the listed pharma co…